Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on November 16, 2026

LeonaBio Reports Third Quarter 2026 Financial Results and Provides Business Update
20/20 BioLabs Reports Third Quarter 2026 Financial Results and Recent Business Updates
ORIC® Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Operational and Rinzimetostat Program Updates
Kyntra Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
CervoMed Presents Interim Data at CTAD 2026 Showing Neflamapimod Reduces Neurodegeneration Biomarker in Nonfluent Variant Primary Progressive Aphasia
Windward Bio Announces Closing of $251.2 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Interpace Biosciences Announces Third Quarter 2026 Financial and Business Results
Daré Bioscience Reports Third Quarter 2026 Financial Results and Highlights Commercial Execution and Pipeline Advancement
Carlsmed to Participate in Upcoming Investor Conferences
Asimov and Emergent Biosolutions Announce Cell Line Development Partnership to Advance Novel Antibodies Against Ebola
Keros Therapeutics Announces Additional $5 Million Share Repurchase Authorization
Rhythm Pharmaceuticals Announces Presentation of New Data at ObesityWeek® 2026
Stipple Bio Announces Multi-Target Multi-Modality Oncology Research Collaboration with Lilly
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Exicure Announces Filing of Notification of Late Filing on Form 12b-25
Galimedix Therapeutics outlines development plans in Alzheimer's disease at CTAD 2026
Joint Statement on the Detainment of Dr. Ann Lawani
SNU Eye Clinic's Dr. Chung Eui Sang Recognized at 2026 Korea & Japan ICL Forum
Family Honors Cancer Patient Peter Arrighi With Fundraising Gift to Expand Access to Expert Cancer Second Opinions
NKGen Biotech Reports Long-Term Clinical Observations with Investigational Alzheimer’s Treatment Troculeucel at CTAD 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia Healthcare Industry Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.